Protocol No. Protocol No. PI Name Title
Pediatric Cancers > Solid Tumors > Neuroblastoma
ANBL1821 NCT03794349 Vo, Kieuhoa Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
ANBL19P1 NCT04385277 Rangaswami, Arun Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)
IRP-101 NCT04724369 Vo, Kieuhoa Open-Label Study of 18F-mFBG for Imaging Neuroblastoma
MIBG 2014-01 NCT03561259 Vo, Kieuhoa A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects (OPTIMUM)
NANT-2004-05 NCT02868268 Vo, Kieuhoa Neuroblastoma Precision Trial
NANT-2015-02 NCT03107988 Vo, Kieuhoa NANT 2015-02: A Phase 1 Study of Lorlatinib (PF-06463922)
NANT-2017-01 NCT03332667 Vo, Kieuhoa MIBG With Dinutuximab +/- Vorinostat
05161 NCT00293319 Vo, Kieuhoa 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma